The Institutional Silence Is the Decision
Health systems promoting AI chatbots have made a structural choice by not addressing the safety literature — and that choice has institutional consequences. When peer-reviewed findings on chatbot misdiagnosis rates circulate on Bluesky the same week a hospital announces a rollout, the absence of a public response is not a communications oversight. It is a liability posture: say nothing, and the evidence cannot be treated as acknowledged.
The Mount Sinai findings on ChatGPT Health's emergency triage failures are the sharpest illustration of what this silence costs. Documented cases where the tool failed to recommend urgent care — cases involving suicide risk — did not produce a public response from OpenAI or from health systems already deploying similar tools. The Mass General Brigham study finding AI chatbots frequently miss diagnoses arrived months later and met the same silence. Institutions that have already deployed are not positioned to respond to evidence that should have paused deployment — so they do not respond, and the tools stay live.